Skip to Main Content (Press Enter)

Logo UNIBS
  • ×
  • Home
  • Persone
  • Strutture
  • Competenze
  • Pubblicazioni
  • Professioni
  • Corsi
  • Insegnamenti
  • Terza Missione

Competenze & Professionalità
Logo UNIBS

|

Competenze & Professionalità

unibs.it
  • ×
  • Home
  • Persone
  • Strutture
  • Competenze
  • Pubblicazioni
  • Professioni
  • Corsi
  • Insegnamenti
  • Terza Missione
  1. Pubblicazioni

BIOCHEMICAL PHARMACOLOGY

Rivista
Codice:
E022049
ISSN:
0006-2952
  • Dati Generali

Dati Generali

Pubblicazioni (13)

  • ascendente
  • decrescente
A novel mechanism for pergolide-induced neuroprotection: inhibition of NF-kappaB nuclear translocation
Articolo
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis
Articolo
Decreased drug accmulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance
Articolo
Different accumulation of cisplatin, oxaliplatin and JM216 in sensitive and cisplatin-resistant human cervical tumour cells.
Articolo
Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication
Articolo
Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication
Articolo
Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines
Articolo
NF-kB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction
Articolo
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo
Articolo
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction
Articolo
Selective inhibition of interleukin-8-induced neutrophil chemotaxis by ketoprofen isomers
Articolo
The PDE4 inhibitor CHF6001 modulates pro-inflammatory cytokines, chemokines and Th1- and Th17-polarizing cytokines in human dendritic cells
Articolo
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons
Articolo
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Assistenza
  • Privacy
  • Utilizzo dei cookie
  • Note legali

Realizzato con VIVO | Designed by Cineca | 26.5.1.0